Nrf2/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats

Pramipexole (PPX), a D2-like receptor agonist, is generally used in the treatment of Parkinson's disease and restless leg syndrome. Its neuroprotective effects have been shown against various neurological disorders. Recent research work has demonstrated that PPX exerts neuroprotection through m...

Descripción completa

Detalles Bibliográficos
Autores principales: Salman, Mohd., Tabassum, Heena, Parvez, Suhel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Company of Biologists Ltd 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449795/
https://www.ncbi.nlm.nih.gov/pubmed/32540990
http://dx.doi.org/10.1242/dmm.045021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449795/
https://www.ncbi.nlm.nih.gov/pubmed/32540990
http://dx.doi.org/10.1242/dmm.045021

Ejemplares similares